IMMUNOPHARMACOLOGY OF 5- (3, 3-DIMETHYL-1-TRIAZENO)-IMIDAZOLE-4-CARBOXAMIDE (DTIC)

被引:28
作者
FIORETTI, MC [1 ]
机构
[1] UNIV PERUGIA,IST PHARMACOL,06100 PERUGIA,ITALY
来源
PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 1975年 / 7卷 / 06期
关键词
D O I
10.1016/0031-6989(75)90009-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:481 / 491
页数:11
相关论文
共 63 条
[1]  
BEAL DD, 1975, J NATL CANCER I, V54, P951
[2]   IMMUNOLOGICAL ALTERATION OF LEUKEMIC CELLS IN-VIVO AFTER TREATMENT WITH AN ANTITUMOR DRUG [J].
BONMASSA.E ;
BONMASSA.A ;
VADLAMUD.S ;
GOLDIN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1970, 66 (04) :1089-&
[3]  
BONMASSAR E, 1975, CANCER RES, V35, P1957
[4]  
BONMASSAR E, 1972, CANCER RES, V32, P1446
[5]  
BONMASSAR E, 1971, Federation Proceedings, V30, P628
[6]  
BONMASSAR E, 1965, ARCH ITAL PATOL CLIN, V8, P231
[7]  
BRUCKNER HW, 1974, CANCER RES, V34, P181
[8]  
BURKE JF, 1970, CANCER RES, V29, P2362
[9]  
BURKE PJ, 1971, CANCER, V27, P744, DOI 10.1002/1097-0142(197103)27:3<744::AID-CNCR2820270335>3.0.CO
[10]  
2-O